Contineum Therapeutics
Clinical trials sponsored by Contineum Therapeutics, explained in plain language.
-
New pill shows promise for MS patients in landmark trial
Disease control CompletedThis study tested an experimental oral medication called PIPE-307 in 182 adults with relapsing-remitting multiple sclerosis (MS). Participants took either a low dose, high dose, or a placebo pill alongside their usual MS treatment for about 30 weeks. The main goals were to check …
Phase: PHASE2 • Sponsor: Contineum Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New pill aims to ease chronic joint and back pain
Symptom relief CompletedThis early-stage study tested whether an experimental oral drug called PIPE-791 is safe and can reduce pain in adults with long-term osteoarthritis knee pain or chronic low back pain. 43 participants stopped their usual pain medicines, then took either the study drug or a placebo…
Phase: PHASE1 • Sponsor: Contineum Therapeutics • Aim: Symptom relief
Last updated May 18, 2026 12:08 UTC